C.A. Hamilton

896 total citations
36 papers, 737 citations indexed

About

C.A. Hamilton is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, C.A. Hamilton has authored 36 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in C.A. Hamilton's work include Receptor Mechanisms and Signaling (11 papers), Pharmacological Effects and Assays (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). C.A. Hamilton is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Pharmacological Effects and Assays (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). C.A. Hamilton collaborates with scholars based in United Kingdom, United States and Netherlands. C.A. Hamilton's co-authors include John L. Reid, JL Reid, Peter J. Barnes, Joel S. Karliner, C. T. Dollery, L. M. H. Wing, H. J. Dargie, C T Dollery, Anna F. Dominiczak and Martin McIntyre and has published in prestigious journals such as The Lancet, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

C.A. Hamilton

35 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.A. Hamilton United Kingdom 14 313 212 202 157 77 36 737
F Lefèvre-Borg France 18 398 1.3× 170 0.8× 300 1.5× 193 1.2× 111 1.4× 28 821
J Velly France 17 355 1.1× 129 0.6× 207 1.0× 184 1.2× 53 0.7× 43 758
Walter Osswald Portugal 17 360 1.2× 182 0.9× 291 1.4× 263 1.7× 69 0.9× 83 920
D. Cambridge United Kingdom 13 394 1.3× 152 0.7× 260 1.3× 249 1.6× 43 0.6× 28 873
Yvonne Vulliemoz United States 16 443 1.4× 209 1.0× 242 1.2× 258 1.6× 39 0.5× 52 1.0k
N B Shepperson United Kingdom 18 559 1.8× 207 1.0× 463 2.3× 284 1.8× 72 0.9× 36 991
R Hahn United States 18 426 1.4× 170 0.8× 377 1.9× 198 1.3× 82 1.1× 44 963
T J Verbeuren Belgium 13 367 1.2× 180 0.8× 359 1.8× 324 2.1× 59 0.8× 25 843
Peter E. Hicks United Kingdom 19 595 1.9× 239 1.1× 433 2.1× 360 2.3× 113 1.5× 49 1.1k
Jai D. Kohli United States 13 276 0.9× 104 0.5× 251 1.2× 127 0.8× 50 0.6× 32 641

Countries citing papers authored by C.A. Hamilton

Since Specialization
Citations

This map shows the geographic impact of C.A. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Hamilton more than expected).

Fields of papers citing papers by C.A. Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.A. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Hamilton. The network helps show where C.A. Hamilton may publish in the future.

Co-authorship network of co-authors of C.A. Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of C.A. Hamilton. A scholar is included among the top collaborators of C.A. Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.A. Hamilton. C.A. Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hood, Becky, et al.. (2013). Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. British Journal of Cancer. 110(1). 123–132. 56 indexed citations
2.
Berry, Colin, C.A. Hamilton, M. Yvonne Alexander, et al.. (2000). Angiotensin II stimulated superoxide production in human arteries. European Heart Journal. 1 indexed citations
3.
McIntyre, Martin, C.A. Hamilton, Daryl D. Rees, John L. Reid, & Anna F. Dominiczak. (1997). Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension. Hypertension. 30(6). 1517–1524. 89 indexed citations
4.
Hamilton, C.A.. (1995). Imidazoline Receptors, Subclassification, and Drug‐Induced Regulation. Annals of the New York Academy of Sciences. 763(1). 57–65. 3 indexed citations
5.
Hamilton, C.A., Éric Thorin, James McCulloch, Marek H Dominiczak, & John L. Reid. (1994). Chronic exposure of bovine aortic endothelial cells to native and oxidized LDL modifies phosphatidylinositol metabolism. Atherosclerosis. 107(1). 55–63. 7 indexed citations
6.
Nixon, Graeme F., C.A. Hamilton, Roger M. Wadsworth, & John L. Reid. (1993). Comparison of Endothelin-1 and Noradrenaline Stimulated Inositol Phosphate Formation in Cultured Aortic Smooth Muscle Cells from Spontaneously Hypertensive and Wistar Kyoto Rats. Blood Pressure. 2(3). 221–227. 6 indexed citations
7.
Hamilton, C.A., Momoh Audu Yakubu, CA Howie, & John L. Reid. (1992). Do Centrally-Acting Antihypertensive Drugs Act at Non-Adrenergic as well as Alpha-2 Adrenoceptor Sites?. Clinical and Experimental Hypertension Part A Theory and Practice. 14(5). 815–835. 9 indexed citations
8.
Yakubu, Momoh Audu, et al.. (1990). Differences in the regulation of [3H]idazoxan and [3H]yohimbine binding sites in the rabbit. European Journal of Pharmacology. 176(3). 305–311. 16 indexed citations
9.
Nixon, Graeme F., C.A. Hamilton, Roger M. Wadsworth, & John L. Reid. (1990). Inositol phosphate formation in arterial smooth muscle from rabbits with perinephritis hypertension. Journal of Hypertension. 8(12). 1155–1160. 7 indexed citations
10.
Deighton, N.M., A. D. Brown, C.A. Hamilton, & John L. Reid. (1988). Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(5). 517–522. 18 indexed citations
11.
Hamilton, C.A., et al.. (1988). α1-Adrenoceptor desensitisation. European Journal of Pharmacology. 152(1-2). 179–183. 4 indexed citations
12.
Yakubu, Momoh Audu, C.A. Hamilton, CA Howie, & JL Reid. (1988). Idazoxan and brain α2-adrenoceptors in the rabbit. Brain Research. 463(2). 289–295. 8 indexed citations
13.
Hamilton, C.A., N.M. Deighton, C. R. Jones, & JL Reid. (1986). Changes in rabbit platelet α and β adrenoceptor number and platelet aggregation. European Journal of Pharmacology. 130(1-2). 145–149. 5 indexed citations
14.
Hamilton, C.A., et al.. (1985). RECOVERY OF a‐ADRRENORECEPTOR MEDIATED RESPONSES AND BINDING SITE NUMBER AFTER INTRAVENOUS BENEXTRAMINE IN THE RABBIT. Journal of Autonomic Pharmacology. 5(1). 13–17. 4 indexed citations
15.
Jones, C. R., C.A. Hamilton, K. Whyte, H. L. Elliott, & JL Reid. (1985). Acute and chronic regulation of α2-adrenoceptor number and function in man. Clinical Science. 68(s10). 129s–132s. 9 indexed citations
16.
Reid, John L., Brian C. Campbell, & C.A. Hamilton. (1984). Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.. Hypertension. 6(5_pt_2). II71–5. 24 indexed citations
17.
Watson, R. Douglas, C.A. Hamilton, John L. Reid, & W A Littler. (1979). Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man.. Hypertension. 1(4). 341–346. 63 indexed citations
18.
Hamilton, C.A., D. H. Jones, H. J. Dargie, & JL Reid. (1978). Does labetalol increase excretion of urinary catecholamines?. BMJ. 2(6140). 800–800. 17 indexed citations
19.
20.
Reid, John L., et al.. (1977). CLONIDINE WITHDRAWAL IN HYPERTENSION. The Lancet. 309(8023). 1171–1174. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Lefèvre-Borg Breakdown of academic impact, for papers by J Velly Breakdown of academic impact, for papers by Walter Osswald Breakdown of academic impact, for papers by D. Cambridge Breakdown of academic impact, for papers by Yvonne Vulliemoz Breakdown of academic impact, for papers by N B Shepperson Breakdown of academic impact, for papers by R Hahn Breakdown of academic impact, for papers by T J Verbeuren Breakdown of academic impact, for papers by Peter E. Hicks Breakdown of academic impact, for papers by Jai D. Kohli
Rankless by CCL
2026